↓ Skip to main content

Dove Medical Press

More Than Three-Fourths of AstraZeneca (ChAdox1 COV-19) COVID-19 Vaccinated Individuals Develop Post Immunization Adverse Event in Northwest Ethiopia

Overview of attention for article published in Infection and Drug Resistance, May 2022
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (65th percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

twitter
4 X users

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
29 Mendeley
Title
More Than Three-Fourths of AstraZeneca (ChAdox1 COV-19) COVID-19 Vaccinated Individuals Develop Post Immunization Adverse Event in Northwest Ethiopia
Published in
Infection and Drug Resistance, May 2022
DOI 10.2147/idr.s360605
Pubmed ID
Authors

Atalay Goshu Muluneh, Mehari Woldemariam Merid, Kassahun Alemu Gelaye, Sewbesew Yitayih Tilahun, Nahom Worku Teshager, Aklilu Yiheyis Abereha, Kalkidan Samuel Sugamo, Mulugeta Ayalew Yimer, Getahun Molla Kassa

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 29 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 29 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 6 21%
Professor > Associate Professor 2 7%
Researcher 2 7%
Student > Postgraduate 1 3%
Professor 1 3%
Other 3 10%
Unknown 14 48%
Readers by discipline Count As %
Nursing and Health Professions 6 21%
Unspecified 1 3%
Biochemistry, Genetics and Molecular Biology 1 3%
Chemical Engineering 1 3%
Business, Management and Accounting 1 3%
Other 3 10%
Unknown 16 55%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 May 2022.
All research outputs
#7,588,133
of 23,849,241 outputs
Outputs from Infection and Drug Resistance
#312
of 1,839 outputs
Outputs of similar age
#148,086
of 430,517 outputs
Outputs of similar age from Infection and Drug Resistance
#19
of 117 outputs
Altmetric has tracked 23,849,241 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 1,839 research outputs from this source. They receive a mean Attention Score of 4.3. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 430,517 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.
We're also able to compare this research output to 117 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.